EX1A-11 CONSENT 10 exhibit1a11-1.htm EXHIBIT 11.1 Algernon NeuroScience Inc.: Exhibit 1A-11.1 - Filed by newsfilecorp.com

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the reference to our firm under the caption "Independent registered public accounting firm" and to the inclusion in this Offering Statement on Form 1-A of our auditors' report dated December 22, 2022, relating to the carve-out financial statements of the DMT Program of Algernon Pharmaceuticals Inc. for the years ended August 31, 2022 and 2021, appearing in the Offering Circular.

 

/s/ Smythe LLP

Chartered Professional Accountants

Vancouver, Canada

December 29, 2022